These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14265058)

  • 1. [HISTOMORPHOLOGICAL FINDINGS ON THE EXCRETORY SEGMENT OF THE PANCREAS IN RATS AFTER THE EFFECT OF ORAL ANTIDIABETICS].
    RUCKES J; LOEW D; KNICK B
    Frankf Z Pathol; 1965 Jan; 74():319-26. PubMed ID: 14265058
    [No Abstract]   [Full Text] [Related]  

  • 2. [QUANTITATIVE STUDY OF NEOGENESIS OF THE ISLANDS OF LANGERHANS OF THE PANCREAS INDUCED BY A HYPOGLYCEMIC SULFONAMIDE, TOLBUTAMIDE].
    LOUBATIERES A; FRUTEAUDELACLOS C; HOUAREAU MH; ALRIC R
    C R Seances Soc Biol Fil; 1963; 157():1652-4. PubMed ID: 14109095
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL EXPERIENCES WITH A NEW ORAL HYPOGLYCEMIC DRUG, ACETOHEXAMIDE].
    CHANIS RA
    Arch Med Panamenos; 1963 Dec; 12():193-206. PubMed ID: 14161953
    [No Abstract]   [Full Text] [Related]  

  • 4. [REMARKS APROPOS OF THE BIGUANIDE-HYPOGLYCEMIC SULFONAMIDE COMBINATION IN PHARMACOLOGY AND CLINICAL PRACTICE].
    STERNE J; HIRSCH C
    Therapie; 1964; 19():563-9. PubMed ID: 14182941
    [No Abstract]   [Full Text] [Related]  

  • 5. Pancreatic function in alloxan "subdiabetic" rats long-term treated with tolbutamide.
    WEBER JW; COLOMBO JP; GOLDBERG RI; SAPERSTEIN S; SHULKIND ML; KANAMEISHI D; FOA PP
    Diabetes; 1961; 10():122-9. PubMed ID: 13783629
    [No Abstract]   [Full Text] [Related]  

  • 6. THE ADAMANTYL GROUP IN MEDICINAL AGENTS. I. HYPOGLYCEMIC N-ARYLSULFONYL-N' -ADAMANTYLUREAS.
    GERZON K; KRUMKALNS EV; BRINDLE RL; MARSHALL FJ; ROOT MA
    J Med Chem; 1963 Nov; 6():760-3. PubMed ID: 14184942
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pancreas histology in a tolbutamide-treated diabetic].
    VERNE J; GUYON J; KERNEIS
    Ann Endocrinol (Paris); 1957; 18(4):671-2. PubMed ID: 13498449
    [No Abstract]   [Full Text] [Related]  

  • 8. A NEW HYPOGLYCEMIC COMPOUND, 1-CYCLOHEXYL-3-(5-INDANYLSULFONYL) UREA.
    LERNER LJ; BIANCHI A; BORMAN A
    Metabolism; 1965 May; 14():578-82. PubMed ID: 14289483
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACTION OF HYPOGLYCEMIC SULFONAMIDES ON THE PRODUCTION OF CO2 BY ADIPOSE TISSUE OF THE RAT EPIDIDYMIS "IN VITRO"].
    MARQUES M; RIETCORREA P
    Folia Endocrinol; 1964 Jun; 17():381-6. PubMed ID: 14210726
    [No Abstract]   [Full Text] [Related]  

  • 10. FURTHER OBSERVATIONS CONCERNING THE HYPERGLYCEMIC ACTIVITY OF BENZOTHIADIAZINES.
    WOLFF FW; PARMLEY WW
    Diabetes; 1964; 13():115-21. PubMed ID: 14127422
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON THE PANCREAS IN WHITE MICE. VI. ON THE EFFECT OF N1-N-BUTYL-BIGUANIDE ON THE GRANULE AND NUCLEAR VOLUME OF BETA CELLS].
    MOHNIKE G; MORITZ V; LIPPMANN HG
    Endokrinologie; 1963 Sep; 45():67-71. PubMed ID: 14090652
    [No Abstract]   [Full Text] [Related]  

  • 12. ISOLATION OF ORALLY EFFECTIVE HYPOGLYCEMIC COMPOUNDS FROM FICUS BENGALENSIS LINN.
    BRAHMACHARI HD; AUGUSTI KT
    Indian J Physiol Pharmacol; 1964 Jan; 8():60-4. PubMed ID: 14248533
    [No Abstract]   [Full Text] [Related]  

  • 13. ON THE PRESENCE OF AN ANTIDIABETIC PRINCIPLE IN MOMORDICA CHARANTIA.
    CHATTERJEE KP
    Indian J Physiol Pharmacol; 1963 Oct; 7():240-4. PubMed ID: 14175615
    [No Abstract]   [Full Text] [Related]  

  • 14. [Electronoptic studies on the pancreas in normal and pathological conditions].
    NORDMANN M; WOLF E
    Virchows Arch Pathol Anat Physiol Klin Med; 1960; 333():54-67. PubMed ID: 14427587
    [No Abstract]   [Full Text] [Related]  

  • 15. [HISTOMORPHOLOGICAL, HISTOCHEMICAL AND PHASE CONTRAST OBSERVATIONS ON THE FASTING PANCREAS OF THE RAT].
    PARADISI F; CAVAZZUTI F
    Arch Ital Mal Appar Dig; 1964; 31():610-4. PubMed ID: 14310131
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE INFLUENCE OF THE CONSTITUENTS OF THE LYTIC COCKTAIL ON THE ACTION OF HYPOGLYCEMIC AGENTS].
    WIEZOREK WD; GRAUPNER K
    Arch Int Pharmacodyn Ther; 1963 Dec; 146():386-91. PubMed ID: 14099587
    [No Abstract]   [Full Text] [Related]  

  • 17. [EXPERIMENTAL BASIS FOR COMBINED TREATMENT OF DIABETES WITH THE BIGUANIDE-SULFONAMIDE ASSOCIATION].
    STERNE J; HIRSCH C
    Diabete; 1964; 12():171-5. PubMed ID: 14173920
    [No Abstract]   [Full Text] [Related]  

  • 18. ORAL HYPOGLYCEMIC DRUGS.
    ARNOLD CR; LAUENER RW
    Can Med Assoc J; 1964 Aug; 91(8):395-6. PubMed ID: 14179543
    [No Abstract]   [Full Text] [Related]  

  • 19. [FATTY LIVER PATHOGENESIS IN CARASSIUS AURATUS IN GLUCOSE-RICH MEDIUM AND ITS ALTERATION BY N1-N-BUTYLBIGUANIDE AND N'-(4-METHYLBENZOYLSULFONYL)-N'-BUTYLUREA (TOLBUTAMIDE)].
    KOEHLER E; LIPPMANN HG
    Acta Biol Med Ger; 1963; 11():866-72. PubMed ID: 14121880
    [No Abstract]   [Full Text] [Related]  

  • 20. EXPERIMENTAL DIABETES AND THE MODE OF ACTION OF THE SULFONYLUREAS. WITH SOME SPECULATIONS ON THE PREVENTION OF DIABETES.
    FOA PP
    Bull Sinai Hosp Detroit; 1964; 12():31-46. PubMed ID: 14156394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.